Join Multiple Stakeholders at a Critical Time to Examine the Changing Health care Landscape Around Copay Accumulator Adjustments, State Copay Legislation, and Compliant Assistance Programs
The Copay Summit is designed to bring multiple stakeholders together, from manufacturers, payers, states, government officials, advocacy and foundational groups, to examine regulations on the use of Copay and Coupon programs, and Copay Accumulator and Maximizers in an evolving health care landscape.
With the evolution the copay accumulator programs, state legislations that ban such programs, and increased uncertainty around the future of coupon and free drug programs, it is imperative pharma and biotech executives come together to cultivate strategies that will move their assistance programs into the future of health care.
Join us to:
- Examine recent regulatory changes including State legislations that ban copay accumulator programs and CMS 2020 Payment Notice
- Address patient affordability challenges and what it takes to create a Center of Excellence
- Explore the Impact of Copay Accumulators on Drug Pricing Transparency
- Provide ROI through effective copay, coupon and free drug programs
Executive Director, Head Patient and Specialty Services Strategy, Operations and Finance
Vice President, Lilly Diabetes, Senior Vice President, Connected Care and Insulins
Eli Lilly and Company